1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Diagnostic and prognostic performance to detect Alzheimer's disease and clinical progression of a novel assay for plasma p-tau217
(
- Contribution to journal › Article
- 2020
-
Mark
Why Is Amyloid-β PET Requested After Performing CSF Biomarkers?
(
- Contribution to journal › Article
- 2016
-
Mark
Posterior accumulation of tau and concordant hypometabolism in an early-onset Alzheimer's disease patient with presenilin-1 mutation
(
- Contribution to journal › Article
- 2015
-
Mark
Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals
(
- Contribution to journal › Article
-
Mark
The role of tau in the pathological process and clinical expression of Huntington's disease
(
- Contribution to journal › Article
- 2014
-
Mark
Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease : ICICLE-PD study
(
- Contribution to journal › Article
-
Mark
Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants
(
- Contribution to journal › Article
-
Mark
Characterizing mild cognitive impairment in incident Parkinson disease : the ICICLE-PD study
(
- Contribution to journal › Article
- 2009
-
Mark
Biomarkers in the Cerebrospinal Fluid and Neurodegeneration in Langerhans Cell Histiocytosis
(
- Contribution to journal › Article
-
Mark
Monitoring of brain interstitial total tau and beta amyloid proteins by microdialysis in patients with traumatic brain injury
(
- Contribution to journal › Article